APO Research
Talk to an analyst

APO RESEARCH · REPORT

Molecular Imaging CRO

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Molecular Imaging CRO Market Analysis and Forecast 2026-2032

5 June 2026191 pages

Choose your research edition.

Industry ResearchMolecular Imaging CRO Industry Research Report 2026111 pages · $2,950 USDIndustry Growth & TrendsGlobal Molecular Imaging CRO Industry Growth and Trends Forecast to 203286 pages · $3,450 USDMarket StructureGlobal Molecular Imaging CRO Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Molecular Imaging CRO Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Molecular Imaging CRO Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Molecular Imaging CRO market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Molecular Imaging CRO is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Molecular Imaging CRO is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Molecular Imaging CRO is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Molecular Imaging CRO is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Molecular Imaging CRO include BioPharma Services, Bruker, Charles River, Enigma Biomedical Group, Imaging Endpoints, Micron, Inc, Minerva Imaging and Oncodesign Services, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Molecular Imaging CRO, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Molecular Imaging CRO, also provides the revenue of main regions and countries. Of the upcoming market potential for Molecular Imaging CRO, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Molecular Imaging CRO revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Molecular Imaging CRO market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Molecular Imaging CRO revenue, projected growth trends, production technology, application and end-user industry.

Molecular Imaging CRO Segment by Company

BioPharma Services

Bruker

Charles River

Enigma Biomedical Group

Imaging Endpoints

Micron, Inc

Minerva Imaging

Oncodesign Services

Molecular Imaging CRO Segment by Type

Radionuclide Molecular Imaging

Optical Molecular Imaging

Magnetic Resonance Molecular Imaging

Molecular Imaging CRO Segment by Application

Drug Development

Cancer Treatment

Others

Molecular Imaging CRO Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Molecular Imaging CRO market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Molecular Imaging CRO and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Molecular Imaging CRO.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Molecular Imaging CRO in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Molecular Imaging CRO company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Molecular Imaging CRO revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Molecular Imaging CRO Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Radionuclide Molecular Imaging Major Player Table 3. Optical Molecular Imaging Major Player Table 4. Magnetic Resonance Molecular Imaging Major Player Table 5. Global Molecular Imaging CRO Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Drug Development Major Player Table 7. Cancer Treatment Major Player Table 8. Others Major Player Table 9. Molecular Imaging CRO Industry Trends Table 10. Molecular Imaging CRO Industry Drivers Table 11. Molecular Imaging CRO Industry Opportunities and Challenges Table 12. Molecular Imaging CRO Industry Restraints Table 13. Global Molecular Imaging CRO Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Molecular Imaging CRO Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Molecular Imaging CRO Market Share by Region (2021-2026) Table 16. Global Molecular Imaging CRO Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Molecular Imaging CRO Market Share by Region (2027-2032) Table 18. Global Molecular Imaging CRO Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Molecular Imaging CRO Revenue Market Share by Players (2021-2026) Table 20. Global Molecular Imaging CRO Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Molecular Imaging CRO Key Players Headquarters & Area Served Table 22. Global Molecular Imaging CRO Players, Product Type & Application Table 23. Global Molecular Imaging CRO Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Molecular Imaging CRO by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Molecular Imaging CRO Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Molecular Imaging CRO Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Molecular Imaging CRO Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Molecular Imaging CRO Revenue Market Share by Type (2021-2026) Table 30. Global Molecular Imaging CRO Revenue Market Share by Type (2027-2032) Table 31. Global Molecular Imaging CRO Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Molecular Imaging CRO Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Molecular Imaging CRO Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Molecular Imaging CRO Revenue Market Share by Application (2021-2026) Table 35. Global Molecular Imaging CRO Revenue Market Share by Application (2027-2032) Table 36. BioPharma Services Company Information Table 37. BioPharma Services Business Overview Table 38. BioPharma Services Molecular Imaging CRO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. BioPharma Services Molecular Imaging CRO Product Portfolio Table 40. BioPharma Services Recent Development Table 41. Bruker Company Information Table 42. Bruker Business Overview Table 43. Bruker Molecular Imaging CRO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Bruker Molecular Imaging CRO Product Portfolio Table 45. Bruker Recent Development Table 46. Charles River Company Information Table 47. Charles River Business Overview Table 48. Charles River Molecular Imaging CRO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Charles River Molecular Imaging CRO Product Portfolio Table 50. Charles River Recent Development Table 51. Enigma Biomedical Group Company Information Table 52. Enigma Biomedical Group Business Overview Table 53. Enigma Biomedical Group Molecular Imaging CRO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Enigma Biomedical Group Molecular Imaging CRO Product Portfolio Table 55. Enigma Biomedical Group Recent Development Table 56. Imaging Endpoints Company Information Table 57. Imaging Endpoints Business Overview Table 58. Imaging Endpoints Molecular Imaging CRO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Imaging Endpoints Molecular Imaging CRO Product Portfolio Table 60. Imaging Endpoints Recent Development Table 61. Micron, Inc Company Information Table 62. Micron, Inc Business Overview Table 63. Micron, Inc Molecular Imaging CRO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Micron, Inc Molecular Imaging CRO Product Portfolio Table 65. Micron, Inc Recent Development Table 66. Minerva Imaging Company Information Table 67. Minerva Imaging Business Overview Table 68. Minerva Imaging Molecular Imaging CRO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Minerva Imaging Molecular Imaging CRO Product Portfolio Table 70. Minerva Imaging Recent Development Table 71. Oncodesign Services Company Information Table 72. Oncodesign Services Business Overview Table 73. Oncodesign Services Molecular Imaging CRO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Oncodesign Services Molecular Imaging CRO Product Portfolio Table 75. Oncodesign Services Recent Development Table 76. North America Molecular Imaging CRO Revenue by Type (2021-2026) & (US$ Million) Table 77. North America Molecular Imaging CRO Revenue by Type (2027-2032) & (US$ Million) Table 78. North America Molecular Imaging CRO Revenue by Application (2021-2026) & (US$ Million) Table 79. North America Molecular Imaging CRO Revenue by Application (2027-2032) & (US$ Million) Table 80. North America Molecular Imaging CRO Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 81. North America Molecular Imaging CRO Revenue by Country (2021-2026) & (US$ Million) Table 82. North America Molecular Imaging CRO Revenue by Country (US$ Million) & (2027-2032) Table 83. Europe Molecular Imaging CRO Revenue by Type (2021-2026) & (US$ Million) Table 84. Europe Molecular Imaging CRO Revenue by Type (2027-2032) & (US$ Million) Table 85. Europe Molecular Imaging CRO Revenue by Application (2021-2026) & (US$ Million) Table 86. Europe Molecular Imaging CRO Revenue by Application (2027-2032) & (US$ Million) Table 87. Europe Molecular Imaging CRO Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 88. Europe Molecular Imaging CRO Revenue by Country (2021-2026) & (US$ Million) Table 89. Europe Molecular Imaging CRO Revenue by Country (US$ Million) & (2027-2032) Table 90. China Molecular Imaging CRO Revenue by Type (2021-2026) & (US$ Million) Table 91. China Molecular Imaging CRO Revenue by Type (2027-2032) & (US$ Million) Table 92. China Molecular Imaging CRO Revenue by Application (2021-2026) & (US$ Million) Table 93. China Molecular Imaging CRO Revenue by Application (2027-2032) & (US$ Million) Table 94. Asia Molecular Imaging CRO Revenue by Type (2021-2026) & (US$ Million) Table 95. Asia Molecular Imaging CRO Revenue by Type (2027-2032) & (US$ Million) Table 96. Asia Molecular Imaging CRO Revenue by Application (2021-2026) & (US$ Million) Table 97. Asia Molecular Imaging CRO Revenue by Application (2027-2032) & (US$ Million) Table 98. Asia Molecular Imaging CRO Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 99. Asia Molecular Imaging CRO Revenue by Region (US$ Million) & (2021-2026) Table 100. Asia Molecular Imaging CRO Revenue by Region (US$ Million) & (2027-2032) Table 101. SAMEA Molecular Imaging CRO Revenue by Type (2021-2026) & (US$ Million) Table 102. SAMEA Molecular Imaging CRO Revenue by Type (2027-2032) & (US$ Million) Table 103. SAMEA Molecular Imaging CRO Revenue by Application (2021-2026) & (US$ Million) Table 104. SAMEA Molecular Imaging CRO Revenue by Application (2027-2032) & (US$ Million) Table 105. SAMEA Molecular Imaging CRO Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 106. SAMEA Molecular Imaging CRO Revenue by Country (2021-2026) & (US$ Million) Table 107. SAMEA Molecular Imaging CRO Revenue by Country (US$ Million) & (2027-2032) Table 108. Research Programs/Design for This Report Table 109. Authors List of This Report Table 110. Secondary Sources Table 111. Primary Sources List of Figures Figure 1. Molecular Imaging CRO Image Figure 2. Global Molecular Imaging CRO Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Molecular Imaging CRO Market Size Share 2021 VS 2025 VS 2032 Figure 4. Radionuclide Molecular Imaging Image Figure 5. Optical Molecular Imaging Image Figure 6. Magnetic Resonance Molecular Imaging Image Figure 7. Global Molecular Imaging CRO Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Molecular Imaging CRO Market Size Share 2021 VS 2025 VS 2032 Figure 9. Drug Development Image Figure 10. Cancer Treatment Image Figure 11. Others Image Figure 12. Global Molecular Imaging CRO Market Size (US$ Million) & (2021-2032) Figure 13. Global Molecular Imaging CRO Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Molecular Imaging CRO Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Molecular Imaging CRO Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Molecular Imaging CRO Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Molecular Imaging CRO Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Molecular Imaging CRO Revenue Market Share by Type (2021-2032) Figure 20. Global Molecular Imaging CRO Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Molecular Imaging CRO Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Molecular Imaging CRO Revenue Market Share by Application (2021-2032) Figure 23. North America Molecular Imaging CRO Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Molecular Imaging CRO Revenue Share by Type (2021-2032) Figure 25. North America Molecular Imaging CRO Revenue Share by Application (2021-2032) Figure 26. North America Molecular Imaging CRO Revenue Share by Country (2021-2032) Figure 27. United States Molecular Imaging CRO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Molecular Imaging CRO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Molecular Imaging CRO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Molecular Imaging CRO Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Molecular Imaging CRO Revenue Share by Type (2021-2032) Figure 32. Europe Molecular Imaging CRO Revenue Share by Application (2021-2032) Figure 33. Europe Molecular Imaging CRO Revenue Share by Country (2021-2032) Figure 34. Germany Molecular Imaging CRO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Molecular Imaging CRO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Molecular Imaging CRO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Molecular Imaging CRO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Molecular Imaging CRO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Molecular Imaging CRO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Molecular Imaging CRO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Molecular Imaging CRO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Molecular Imaging CRO Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Molecular Imaging CRO Revenue Share by Type (2021-2032) Figure 44. China Molecular Imaging CRO Revenue Share by Application (2021-2032) Figure 45. Asia Molecular Imaging CRO Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Molecular Imaging CRO Revenue Share by Type (2021-2032) Figure 47. Asia Molecular Imaging CRO Revenue Share by Application (2021-2032) Figure 48. Asia Molecular Imaging CRO Revenue Share by Region (2021-2032) Figure 49. Japan Molecular Imaging CRO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Molecular Imaging CRO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Molecular Imaging CRO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Molecular Imaging CRO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Molecular Imaging CRO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Molecular Imaging CRO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Molecular Imaging CRO Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Molecular Imaging CRO Revenue Share by Type (2021-2032) Figure 57. SAMEA Molecular Imaging CRO Revenue Share by Application (2021-2032) Figure 58. SAMEA Molecular Imaging CRO Revenue Share by Country (2021-2032) Figure 59. Brazil Molecular Imaging CRO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Molecular Imaging CRO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Molecular Imaging CRO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Molecular Imaging CRO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Molecular Imaging CRO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Molecular Imaging CRO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Molecular Imaging CRO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Molecular Imaging CRO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Molecular Imaging CRO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Molecular Imaging CRO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Molecular Imaging CRO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Radionuclide Molecular Imaging
  • Optical Molecular Imaging
  • Magnetic Resonance Molecular Imaging
Applications
  • Drug Development
  • Cancer Treatment
  • Others
Companies covered
  • BioPharma Services
  • Bruker
  • Charles River
  • Enigma Biomedical Group
  • Imaging Endpoints
  • Micron, Inc
  • Minerva Imaging
  • Oncodesign Services

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Molecular Imaging CRO Market by Type
  3. 1.2.1 Global Molecular Imaging CRO Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Radionuclide Molecular Imaging
  5. 1.2.3 Optical Molecular Imaging
  6. 1.2.4 Magnetic Resonance Molecular Imaging
  7. 1.3 Molecular Imaging CRO Market by Application
  8. 1.3.1 Global Molecular Imaging CRO Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Drug Development
  10. 1.3.3 Cancer Treatment
  11. 1.3.4 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Molecular Imaging CRO Market Dynamics
  1. 2.1 Molecular Imaging CRO Industry Trends
  2. 2.2 Molecular Imaging CRO Industry Drivers
  3. 2.3 Molecular Imaging CRO Industry Opportunities and Challenges
  4. 2.4 Molecular Imaging CRO Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Molecular Imaging CRO Market Perspective (2021-2032)
  2. 3.2 Global Molecular Imaging CRO Growth Trends by Region
  3. 3.2.1 Global Molecular Imaging CRO Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Molecular Imaging CRO Market Size by Region (2021-2026)
  5. 3.2.3 Global Molecular Imaging CRO Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Molecular Imaging CRO Revenue by Players
  2. 4.1.1 Global Molecular Imaging CRO Revenue by Players (2021-2026)
  3. 4.1.2 Global Molecular Imaging CRO Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Molecular Imaging CRO Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Molecular Imaging CRO Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Molecular Imaging CRO Key Players Headquarters & Area Served
  7. 4.4 Global Molecular Imaging CRO Players, Product Type & Application
  8. 4.5 Global Molecular Imaging CRO Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Molecular Imaging CRO Market CR5 and HHI
  11. 4.6.3 2025 Molecular Imaging CRO Tier 1, Tier 2, and Tier 3
5 Molecular Imaging CRO Market Size by Type
  1. 5.1 Global Molecular Imaging CRO Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Molecular Imaging CRO Revenue by Type (2021-2032)
  3. 5.3 Global Molecular Imaging CRO Revenue Market Share by Type (2021-2032)
6 Molecular Imaging CRO Market Size by Application
  1. 6.1 Global Molecular Imaging CRO Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Molecular Imaging CRO Revenue by Application (2021-2032)
  3. 6.3 Global Molecular Imaging CRO Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 BioPharma Services
  2. 7.1.1 BioPharma Services Company Information
  3. 7.1.2 BioPharma Services Business Overview
  4. 7.1.3 BioPharma Services Molecular Imaging CRO Revenue and Gross Margin (2021-2026)
  5. 7.1.4 BioPharma Services Molecular Imaging CRO Product Portfolio
  6. 7.1.5 BioPharma Services Recent Developments
  7. 7.2 Bruker
  8. 7.2.1 Bruker Company Information
  9. 7.2.2 Bruker Business Overview
  10. 7.2.3 Bruker Molecular Imaging CRO Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Bruker Molecular Imaging CRO Product Portfolio
  12. 7.2.5 Bruker Recent Developments
  13. 7.3 Charles River
  14. 7.3.1 Charles River Company Information
  15. 7.3.2 Charles River Business Overview
  16. 7.3.3 Charles River Molecular Imaging CRO Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Charles River Molecular Imaging CRO Product Portfolio
  18. 7.3.5 Charles River Recent Developments
  19. 7.4 Enigma Biomedical Group
  20. 7.4.1 Enigma Biomedical Group Company Information
  21. 7.4.2 Enigma Biomedical Group Business Overview
  22. 7.4.3 Enigma Biomedical Group Molecular Imaging CRO Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Enigma Biomedical Group Molecular Imaging CRO Product Portfolio
  24. 7.4.5 Enigma Biomedical Group Recent Developments
  25. 7.5 Imaging Endpoints
  26. 7.5.1 Imaging Endpoints Company Information
  27. 7.5.2 Imaging Endpoints Business Overview
  28. 7.5.3 Imaging Endpoints Molecular Imaging CRO Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Imaging Endpoints Molecular Imaging CRO Product Portfolio
  30. 7.5.5 Imaging Endpoints Recent Developments
  31. 7.6 Micron, Inc
  32. 7.6.1 Micron, Inc Company Information
  33. 7.6.2 Micron, Inc Business Overview
  34. 7.6.3 Micron, Inc Molecular Imaging CRO Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Micron, Inc Molecular Imaging CRO Product Portfolio
  36. 7.6.5 Micron, Inc Recent Developments
  37. 7.7 Minerva Imaging
  38. 7.7.1 Minerva Imaging Company Information
  39. 7.7.2 Minerva Imaging Business Overview
  40. 7.7.3 Minerva Imaging Molecular Imaging CRO Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Minerva Imaging Molecular Imaging CRO Product Portfolio
  42. 7.7.5 Minerva Imaging Recent Developments
  43. 7.8 Oncodesign Services
  44. 7.8.1 Oncodesign Services Company Information
  45. 7.8.2 Oncodesign Services Business Overview
  46. 7.8.3 Oncodesign Services Molecular Imaging CRO Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Oncodesign Services Molecular Imaging CRO Product Portfolio
  48. 7.8.5 Oncodesign Services Recent Developments
8 North America
  1. 8.1 North America Molecular Imaging CRO Revenue (2021-2032)
  2. 8.2 North America Molecular Imaging CRO Revenue by Type (2021-2032)
  3. 8.2.1 North America Molecular Imaging CRO Revenue by Type (2021-2026)
  4. 8.2.2 North America Molecular Imaging CRO Revenue by Type (2027-2032)
  5. 8.3 North America Molecular Imaging CRO Revenue Share by Type (2021-2032)
  6. 8.4 North America Molecular Imaging CRO Revenue by Application (2021-2032)
  7. 8.4.1 North America Molecular Imaging CRO Revenue by Application (2021-2026)
  8. 8.4.2 North America Molecular Imaging CRO Revenue by Application (2027-2032)
  9. 8.5 North America Molecular Imaging CRO Revenue Share by Application (2021-2032)
  10. 8.6 North America Molecular Imaging CRO Revenue by Country
  11. 8.6.1 North America Molecular Imaging CRO Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Molecular Imaging CRO Revenue by Country (2021-2026)
  13. 8.6.3 North America Molecular Imaging CRO Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Molecular Imaging CRO Revenue (2021-2032)
  2. 9.2 Europe Molecular Imaging CRO Revenue by Type (2021-2032)
  3. 9.2.1 Europe Molecular Imaging CRO Revenue by Type (2021-2026)
  4. 9.2.2 Europe Molecular Imaging CRO Revenue by Type (2027-2032)
  5. 9.3 Europe Molecular Imaging CRO Revenue Share by Type (2021-2032)
  6. 9.4 Europe Molecular Imaging CRO Revenue by Application (2021-2032)
  7. 9.4.1 Europe Molecular Imaging CRO Revenue by Application (2021-2026)
  8. 9.4.2 Europe Molecular Imaging CRO Revenue by Application (2027-2032)
  9. 9.5 Europe Molecular Imaging CRO Revenue Share by Application (2021-2032)
  10. 9.6 Europe Molecular Imaging CRO Revenue by Country
  11. 9.6.1 Europe Molecular Imaging CRO Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Molecular Imaging CRO Revenue by Country (2021-2026)
  13. 9.6.3 Europe Molecular Imaging CRO Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Molecular Imaging CRO Revenue (2021-2032)
  2. 10.2 China Molecular Imaging CRO Revenue by Type (2021-2032)
  3. 10.2.1 China Molecular Imaging CRO Revenue by Type (2021-2026)
  4. 10.2.2 China Molecular Imaging CRO Revenue by Type (2027-2032)
  5. 10.3 China Molecular Imaging CRO Revenue Share by Type (2021-2032)
  6. 10.4 China Molecular Imaging CRO Revenue by Application (2021-2032)
  7. 10.4.1 China Molecular Imaging CRO Revenue by Application (2021-2026)
  8. 10.4.2 China Molecular Imaging CRO Revenue by Application (2027-2032)
  9. 10.5 China Molecular Imaging CRO Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Molecular Imaging CRO Revenue (2021-2032)
  2. 11.2 Asia Molecular Imaging CRO Revenue by Type (2021-2032)
  3. 11.2.1 Asia Molecular Imaging CRO Revenue by Type (2021-2026)
  4. 11.2.2 Asia Molecular Imaging CRO Revenue by Type (2027-2032)
  5. 11.3 Asia Molecular Imaging CRO Revenue Share by Type (2021-2032)
  6. 11.4 Asia Molecular Imaging CRO Revenue by Application (2021-2032)
  7. 11.4.1 Asia Molecular Imaging CRO Revenue by Application (2021-2026)
  8. 11.4.2 Asia Molecular Imaging CRO Revenue by Application (2027-2032)
  9. 11.5 Asia Molecular Imaging CRO Revenue Share by Application (2021-2032)
  10. 11.6 Asia Molecular Imaging CRO Revenue by Country
  11. 11.6.1 Asia Molecular Imaging CRO Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Molecular Imaging CRO Revenue by Country (2021-2026)
  13. 11.6.3 Asia Molecular Imaging CRO Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Molecular Imaging CRO Revenue (2021-2032)
  2. 12.2 SAMEA Molecular Imaging CRO Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Molecular Imaging CRO Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Molecular Imaging CRO Revenue by Type (2027-2032)
  5. 12.3 SAMEA Molecular Imaging CRO Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Molecular Imaging CRO Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Molecular Imaging CRO Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Molecular Imaging CRO Revenue by Application (2027-2032)
  9. 12.5 SAMEA Molecular Imaging CRO Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Molecular Imaging CRO Revenue by Country
  11. 12.6.1 SAMEA Molecular Imaging CRO Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Molecular Imaging CRO Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Molecular Imaging CRO Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst